Roles of virulence genes (PsaA and CpsA) on the invasion of Streptococcus pneumoniae into blood system

European Journal of Medical Research

Volumn 18, Issue 1, 2013, Pages

  Hu, Da Kang ^a   Wang, Dong Guo ^a   Liu, Yang ^a   Liu, Chi Bo ^a   Yu, Lian Hua ^a   Qu, Ying ^a   Luo, Xin Hua ^a   Yang, Jin Hong ^a   Yu, Jian ^a   Zhang, Jin ^a   Li, Xiang Yang ^a  

^a TAIZHOU MUNICIPAL HOSPITAL   (China)

Author keywords

CpsA; PsaA; Real time PCR; Streptococcus pneumonia; Virulence gene

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL RNA; CPSA PROTEIN; MESSENGER RNA; PSAA PROTEIN; UNCLASSIFIED DRUG; ADHESIN; CPSA PROTEIN, STREPTOCOCCUS PNEUMONIAE; LIPOPROTEIN; PSAA PROTEIN, STREPTOCOCCUS;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BLOOD; CONTROLLED STUDY; GENE EXPRESSION; HOSPITAL PATIENT; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; STREPTOCOCCUS PNEUMONIAE; CELL LINE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; LUNG ALVEOLUS CELL; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; SPUTUM; STREPTOCOCCUS PNEUMONIA;

ADHESINS, BACTERIAL; BACTERIAL PROTEINS; BLOOD; CELL LINE; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; LIPOPROTEINS; MONOCYTES; PNEUMOCYTES; PNEUMONIA, PNEUMOCOCCAL; SPUTUM; STREPTOCOCCUS PNEUMONIAE;

EID: 84877824790     PISSN: 09492321     EISSN: 2047783X     Source Type: Journal    
DOI: 10.1186/2047-783X-18-14     Document Type: Article

References (30)

1. Simple, accurate, serotype-specific PCR assay to differentiate Streptococcus pneumoniae serotypes 6A, 6B, and 6C. Jin P, Xiao M, Kong F, Oftadeh S, Zhou F, Liu C, Gilbert GL, J Clin Microbiol 2009 47 2470 2474 10.1128/JCM.00484-09 19535528
2. Pneumococcal virulence gene expression and host cytokine profiles during pathogenesis of invasive disease. Mahdi LK, Ogunniyi AD, LeMessurier KS, Paton JC, Infect Immun 2008 76 646 657 10.1128/IAI.01161-07 18039836
3. Mode of action of long-term low-dose macrolide therapy for chronic sinusitis in the light of neutrophil recruitment. Suzuki H, Ikeda K, Curr Drug Targets Inflamm Allergy 2002 1 117 126 10.2174/1568010023344832 14561211
4. Attachment of capsular polysaccharide to the cell wall of Streptococcus pneumoniae type 2 is required for invasive disease. Morona JK, Morona R, Paton JC, Proc Natl Acad Sci USA 2006 103 8505 8510 10.1073/pnas.0602148103 16707578
5. Pneumolysin induces release of matrix metalloproteinase-8 and -9 from human neutrophils. Cockeran R, Mitchell TJ, Feldman C, Anderson R, Eur Respir J 2009 34 1167 1170 10.1183/09031936.00007109 19880617
6. The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion. Uchiyama S, Carlin AF, Khosravi A, Weiman S, Banerjee A, Quach D, Hightower G, Mitchell TJ, Doran KS, Nizet V, J Exp Med 2009 206 1845 1852 10.1084/jem.20090386 19687228
7. The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms. Hyams C, Camberlein E, Cohen JM, Bax K, Brown JS, Infect Immun 2010 78 704 715 10.1128/IAI.00881-09 19948837
8. Differential activation of inflammatory pathways in A549 type II pneumocytes by Streptococcus pneumoniae strains with different adherence properties. Robson RL, Reed NA, Horvat RT, BMC Infect Dis 2006 6 71 10.1186/1471-2334-6-71 16606470
9. THP-1 monocytes up-regulate intercellular adhesion molecule 1 in response to pneumolysin from Streptococcus pneumoniae. Thornton J, McDaniel LS, Infect Immun 2005 73 6493 6498 10.1128/IAI.73.10.6493-6498.2005 16177322
10. Pathogenesis and pathophysiology of pneumococcal meningitis. Koedel U, Scheld WM, Pfister HW, Lancet Infect Dis 2002 2 721 736 10.1016/S1473-3099(02) 00450-4 12467688
11. Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Weisfelt M, van de Beek D, Spanjaard L, Reitsma JB, de Gans J, Lancet Neurol 2006 5 123 129 10.1016/S1474-4422(05)70288- X 16426988
12. Virulence of pneumococcal proteins on the inner ear. Schachern PA, Tsuprun V, Cureoglu S, Ferrieri P, Briles DE, Paparella MM, Juhn S, Arch Otolaryngol Head Neck Surg 2009 135 657 661 10.1001/archoto.2009.72 19620586
13. Streptococcus pneumoniae evades human dendritic cell surveillance by pneumolysin expression. Littmann M, Albiger B, Frentzen A, Normark S, Henriques-Normark B, Plant L, EMBO Mol Med 2009 1 211 222 10.1002/emmm.200900025 20049723
14. Unique variations of pbp2b sequences in penicillin-nonsusceptible Streptococcus pneumoniae isolates from Korea. Baek JY, Ko KS, Oh WS, Jung SI, Kim YS, Chang HH, Lee H, Kim SW, Peck KR, Lee NY, Song JH, J Clin Microbiol 2004 42 1746 1750 10.1128/JCM.42.4.1746-1750.2004 15071038
15. Rapid detection of penicillin-resistant Streptococcus pneumoniae in cerebrospinal fluid by a seminested-PCR strategy. du Plessis M, Smith AM, Klugman KP, J Clin Microbiol 1998 36 453 457 9466757
16. Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae. Berry AM, Paton JC, Infect Immun 1996 64 5255 5262 8945574
17. The type 2 capsule locus of Streptococcus pneumoniae. Iannelli F, Pearce BJ, Pozzi G, J Bacteriol 1999 181 2652 2654 10198036
18. Intrageneric structure of Streptococcus based on comparative analysis of small-subunit rRNA sequences. Bentley RW, Leigh JA, Collins MD, Int J Syst Bacteriol 1991 41 487 494 10.1099/00207713-41-4-487 1720654
19. Monoclonal antibody recognizing a species-specific protein from Streptococcus pneumoniae. Russell H, Tharpe JA, Wells DE, White EH, Johnson JE, J Clin Microbiol 1990 28 2191 2195 2229341
20. Cloning and nucleotide sequence analysis of psaA, the Streptococcus pneumoniae gene encoding a 37-kilodalton protein homologous to previously reported Streptococcus sp. adhesins. Sampson JS, O'Connor SP, Stinson AR, Tharpe JA, Russell H, Infect Immun 1994 62 319 324 7505262
21. Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. Bentley SD, Aanensen DM, Mavroidi A, Saunders D, Rabbinowitsch E, Collins M, Donohoe K, Harris D, Murphy L, Quail MA, Samuel G, Skovsted IC, Kaltoft MS, Barrell B, Reeves PR, Parkhill J, Spratt BG, PLoS Genet 2006 2 31 10.1371/journal.pgen.0020031 16532061
22. Evolutionary genetics of the capsular locus of serogroup 6 pneumococci. Mavroidi A, Godoy D, Aanensen DM, Robinson DA, Hollingshead SK, Spratt BG, J Bacteriol 2004 186 8181 8192 10.1128/JB.186.24.8181-8192.2004 15576766
23. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Briles DE, Crain MJ, Gray BM, Forman C, Yother J, Infect Immun 1992 60 111 116 1729176
24. Interruption of capsule production in Streptococcus pneumonia serotype 3 by insertion of transposon Tn916. Watson DA, Musher DM, Infect Immun 1990 58 3135 3138 2167295
25. The inhibition of surface phagocytosis by the capsular slime layer of pneumococcus type III. Wood WB Jr, Smith MR, J Exp Med 1949 90 85 96 10.1084/jem.90.1.85 18152341
26. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, Spratt BG, J Infect Dis 2004 190 1203 1211 10.1086/423820 15346329
27. Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae. Kelly T, Dillard JP, Yother J, Infect Immun 1994 62 1813 1819 8168944
28. Heterogeneity of pneumococcal phase variants in invasive human infections. Serrano I, Melo-Cristino J, Ramirez M, BMC Microbiol 2006 6 67 10.1186/1471-2180-6-67 16872486
29. Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance. Nelson AL, Roche AM, Gould JM, Chim K, Ratner AJ, Weiser JN, Infect Immun 2007 75 83 90 10.1128/IAI.01475-06 17088346
30. Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps. Wartha F, Beiter K, Albiger B, Fernebro J, Zychlinsky A, Normark S, Henriques-Normark B, Cell Microbiol 2007 9 1162 1171 10.1111/j.1462-5822.2006.00857.x 17217430